A detailed history of Caisse De Depot Et Placement Du Quebec transactions in Neurocrine Biosciences Inc stock. As of the latest transaction made, Caisse De Depot Et Placement Du Quebec holds 656,118 shares of NBIX stock, worth $82.3 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
656,118
Previous 151,683 332.56%
Holding current value
$82.3 Million
Previous $20.9 Million 331.77%
% of portfolio
0.22%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$130.86 - $143.19 $66 Million - $72.2 Million
504,435 Added 332.56%
656,118 $90.3 Million
Q1 2024

May 14, 2024

BUY
$130.4 - $143.74 $10 Million - $11.1 Million
76,938 Added 102.93%
151,683 $20.9 Million
Q4 2023

Feb 14, 2024

BUY
$106.07 - $132.76 $1.5 Million - $1.88 Million
14,156 Added 23.36%
74,745 $9.85 Million
Q3 2023

Nov 14, 2023

SELL
$94.02 - $117.1 $10.2 Million - $12.7 Million
-108,080 Reduced 64.08%
60,589 $6.82 Million
Q2 2023

Aug 14, 2023

SELL
$89.53 - $104.87 $15.6 Million - $18.2 Million
-173,763 Reduced 50.74%
168,669 $15.9 Million
Q1 2023

May 12, 2023

BUY
$94.11 - $123.02 $28.1 Million - $36.7 Million
298,056 Added 671.66%
342,432 $34.7 Million
Q4 2022

Feb 14, 2023

BUY
$106.72 - $127.06 $2.29 Million - $2.73 Million
21,500 Added 93.98%
44,376 $5.3 Million
Q3 2022

Nov 14, 2022

BUY
$92.03 - $107.81 $1.9 Million - $2.22 Million
20,623 Added 915.36%
22,876 $2.43 Million
Q2 2022

Aug 12, 2022

SELL
$75.79 - $100.07 $1.71 Million - $2.25 Million
-22,516 Reduced 90.9%
2,253 $220,000
Q1 2022

May 13, 2022

BUY
$72.45 - $94.81 $492,660 - $644,708
6,800 Added 37.84%
24,769 $2.32 Million
Q4 2021

Feb 14, 2022

SELL
$79.65 - $106.22 $103,545 - $138,086
-1,300 Reduced 6.75%
17,969 $1.53 Million
Q3 2021

Nov 12, 2021

BUY
$86.18 - $99.03 $344,720 - $396,120
4,000 Added 26.2%
19,269 $1.85 Million
Q2 2021

Aug 13, 2021

BUY
$89.43 - $102.27 $1.37 Million - $1.56 Million
15,269 New
15,269 $1.49 Million

Others Institutions Holding NBIX

About NEUROCRINE BIOSCIENCES INC


  • Ticker NBIX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 95,639,296
  • Market Cap $12B
  • Description
  • Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...
More about NBIX
Track This Portfolio

Track Caisse De Depot Et Placement Du Quebec Portfolio

Follow Caisse De Depot Et Placement Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caisse De Depot Et Placement Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Caisse De Depot Et Placement Du Quebec with notifications on news.